{
    "clinical_study": {
        "@rank": "141150", 
        "acronym": "ESCAPE", 
        "arm_group": {
            "arm_group_label": "Amisulpride", 
            "arm_group_type": "Experimental", 
            "description": "Patients are treated with Amisulpride referring to the dosage and usage section in Chinese Solian\u00ae PI. Amisulpride dosage is adjusted based on individual response and reaches the sufficiency within 1 week"
        }, 
        "brief_summary": {
            "textblock": "Primary Objective:\n\n      To evaluate the effectiveness of amisulpride in Chinese patients with schizophrenia\n\n      Secondary Objective:\n\n      To evaluate the overall safety of amisulpride in Chinese patients with schizophrenia."
        }, 
        "brief_title": "Effectiveness and Safety of Amisulpride in Chinese Patients With Schizophrenia", 
        "completion_date": {
            "#text": "December 2013", 
            "@type": "Actual"
        }, 
        "condition": "Schizophrenia", 
        "condition_browse": {
            "mesh_term": "Schizophrenia"
        }, 
        "detailed_description": {
            "textblock": "The study duration by subject will include a 8-week treatment period with 3 follow-up\n      visits."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion criteria :\n\n          -  Satisfying International Classification of Disease-10 (ICD) diagnostic criteria of\n             schizophrenia;\n\n          -  Positive and Negative Syndrome Scale (PANSS) total score \u2265 60\n\n        Exclusion criteria:\n\n          -  Refractory schizophrenia or Patients treated with sufficient clozapine for a minimum\n             period of 6-8 weeks without improvement;\n\n          -  Participation into another clinical trial within the past 3 months;\n\n          -  Patients previously or currently treated with amisulpride;\n\n          -  Patients receiving clozapine within the past 1 month or treated with long-acting\n             formulation of  antipsychotic medication within the past 2 months;\n\n          -  Patients receiving electric convulsive therapy or physical therapy within the past 1\n             month;\n\n          -  Patients with coexisting severe systemic diseases;\n\n        The above information is not intended to contain all considerations relevant to a\n        patient's potential participation in a clinical trial."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "65 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "304", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "February 18, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01795183", 
            "org_study_id": "AMISUL06155", 
            "secondary_id": "U1111-1131-0692"
        }, 
        "intervention": {
            "arm_group_label": "Amisulpride", 
            "description": "Pharmaceutical form: tablet Route of administration: oral", 
            "intervention_name": "AMISULPRIDE", 
            "intervention_type": "Drug", 
            "other_name": "Solian"
        }, 
        "intervention_browse": {
            "mesh_term": [
                "Sultopride", 
                "Sulpiride"
            ]
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "January 7, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Beijing", 
                    "country": "China"
                }, 
                "name": "Sanofi-Aventis Administrative Office"
            }
        }, 
        "location_countries": {
            "country": "China"
        }, 
        "number_of_arms": "1", 
        "official_title": "The Effectiveness and Safety of Amisulpride in Chinese Patients With Schizophrenia", 
        "overall_official": {
            "affiliation": "Sanofi", 
            "last_name": "Clinical Sciences & Operations", 
            "role": "Study Director"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "China: Ministry of Health", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "December 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "Effective percentage (PANSS score reduced rate\u226550%)", 
            "safety_issue": "Yes", 
            "time_frame": "Week 8"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01795183"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Early response rate (PANSS score reduced rate: at least 20%)", 
                "safety_issue": "Yes", 
                "time_frame": "week 2"
            }, 
            {
                "measure": "Positive and Negative Syndrome Scale (PANSS)-total score improvement", 
                "safety_issue": "Yes", 
                "time_frame": "Baseline, Week 8"
            }, 
            {
                "measure": "Clinical Global Impression Scale- Improvement (CGI-I)", 
                "safety_issue": "Yes", 
                "time_frame": "Baseline, Week 8"
            }
        ], 
        "source": "Sanofi", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Sanofi", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "November 2012", 
        "study_design": "Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "January 2014"
    }
}